August 18, 2020
1:00 PM to 4:30 PM (EDT)
Inspiring Multiplexing Innovation
Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well. xMAP® Technology uses color-coded microspheres as the substrate on which the solution-phase assays are performed. The microspheres, also known as beads, are read in an xMAP® analyzer. Luminex’s xMAP® Technology offers the versatility to perform a wide range of protein or nucleic acid based multiplex assays on a single platform.
Now more than ever, robust protein detection methods are necessary to accurately quantify biomarkers. Your time and samples are too precious to trust anything but the most highly verified multiplex assays for Luminex®. Based on Luminex® xMAP® technology, MilliporeSigma’s MILLIPLEX® portfolio of immunoassays is the largest portfolio of multiplex biomarker assays offering you consistent, high-quality results, so that you can do your best work while saving time, labor and cost. Robust assay performance data is included in every protocol ensuring the highest quality data.
Most conferences focus on research advances or the development of therapies for specific diseases—xMAP® Connect is different.
Whether you’re a multiplexing expert or just getting started, xMAP Connect is the premier event for connecting with fellow xMAP enthusiasts, and learning about best practices for multiplex assays. Now, you can experience what xMAP Connect has to offer virtually from anywhere in the world.
During this program, you can hear from multiplex experts about how they’ve developed, validated, and optimized their methods, as well as learn about innovative research and clinical applications of xMAP Technology.
1:00 to 1:45 - Multiplexing with xMAP 101
1:45 to 2:30 - Measuring the Storm: using Milliplex assays to assess cytokine storm syndrome
2:30 to 3:15 - Lessons Learned in the Pursuit of High Throughput Luminex Analysis on a Budget
3:15 to 4:00 - Belysa: curve fitting software for your immunoassay data
4:00 to 4:30 - Breakout sessions
Technology Performance Overview - Sherry Dunbar, PhD, Senior Director, Global Scientific Affairs, Luminex
Rapid Development of Multiplex Serological Assays for COVID-19 and Beyond - Steve Angeloni, PhD, Field Application Scientist, Luminex
An Alternative to Western Blotting: Cell Signaling Multiplexing Assays - Stanley Kimani, PhD, Immunoassay Field Application Scientist, MilliporeSigma
Industry Guidelines for Biomarker Assay Selection - Lawrence Rentoul, Global Immunoassay Product Manager, MilliporeSigma
Join the xMAP Connect to:
- Participate in seminars and small break-out sessions — by scientists, for scientists—to gain insights from NIH experts on how to optimize multiplex assays
- Connect with application scientists to get multiplexing tips and tricks, plus troubleshooting help
- Visit with Luminex and MilliporeSigma to learn more about custom and kit based multiplexing solutions
Registration deadline is August 14, 2020 at 5:00 PM (EDT).